Logo

Illumina Ventures: Ron Mazumder, Lisa Alderson

Jan 24, 2023

Illumina ventures announced that Abhijit "Ron" Mazumder has joined as a partner and Lisa Alderson has joined as an entrepreneur in residence.

Most recently, Mazumder was VP and global head of oncology biomarker development and companion diagnostics at Genentech. He has also developed diagnostics and biomarkers for Johnson and Johnson and Merck. He holds a doctorate in biochemistry from the University of Maryland and an MBA from Lehigh University.

Alderson cofounded and served as CEO of Genome Medical. She was also chief commercial officer and chief strategy officer at Invitae. She holds an MBA from Harvard Business School.

Breaking News
The Scan

Cystatin C Plays Role in Immunosuppression, Cancer Immunotherapy Failure, Study Finds

A study in Cell Genomics provides insight into how glucocorticoids can lead to cancer immunotherapy failure via cystatin C production.

Aging, Species Lifespan Gene Expression Signatures Overlap

An Osaka Metropolitan University team reports in Nucleic Acids Research that transcriptional signatures of aging and maximum lifespan have similarities.

Splicing Subgroup Provides Protocols for Evaluating Splicing Variant Data

The group presents their approach on how to apply evidence codes to splicing predictions and other data in the American Journal of Human Genetics.

Single-Cell Transcriptomic Atlas of Mouse Cochlea to Aid Treatment Development

Researchers in PNAS conducted single-cell and single-nuclear sequencing of about 120,000 cells at three key timepoints in cochlear development to generate a transcriptomic atlas.